Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricard Ferrer

Showing results (181-190 of 319) with videos related to

Pageof 32
Sort By:
Frontiers in Immunology|June 18, 2021
Hemadsorption as a Treatment Option for Multisystem Inflammatory Syndrome in Children Associated With COVID-19. A Case ReportJuan Carlos Ruiz-Rodríguez, Luis Chiscano-Camón, Clara Palmada, et al.
Archivos De Bronconeumologia|September 27, 2022
Hyperglycemia in Acute Critically Ill COVID-19 PatientsCatia Cilloniz, Juan M Pericàs, Anna Motos, et al.
Frontiers in Immunology|December 6, 2021
JAK2-STAT Epigenetically Regulates Tolerized Genes in Monocytes in the First Encounter With Gram-Negative Bacterial Endotoxins in SepsisOctavio Morante-Palacios, Clara Lorente-Sorolla, Laura Ciudad, et al.
Intensive Care Medicine|January 2, 2023
How to use biomarkers of infection or sepsis at the bedside: guide to cliniciansPedro Póvoa, Luís Coelho, Felipe Dal-Pizzol, et al.
Critical Care Explorations|October 16, 2020
Extracorporeal Membrane Oxygenation Retrieval in Coronavirus Disease 2019: A Case-Series of 19 Patients Supported at a High-Volume Extracorporeal Membrane Oxygenation CenterJordi Riera, Eduard Argudo, María Martínez-Martínez, et al.
International Angiology : a Journal of the International Union of Angiology|November 9, 2021
Mortality and bleeding complications of COVID-19 critically ill patients with venous thromboembolismDaniel Gil-Sala, Claudia Riera, Marvin García-Reyes, et al.
Antibiotics (Basel, Switzerland)|January 25, 2025
Correction: Kirkegaard-Biosca et al. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. <i>Antibiotics</i> 2024, <i>13</i>, 874Cristina Kirkegaard-Biosca, Ester Del Barrio-Tofiño, Miguel Villamarín, et al.
Antibiotics (Basel, Switzerland)|September 28, 2024
Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative BacteriaCristina Kirkegaard-Biosca, Ester Del Barrio-Tofiño, Miguel Villamarín, et al.
The Lancet. Infectious Diseases|October 15, 2020
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trialMatteo Bassetti, Roger Echols, Yuko Matsunaga, et al.
International Journal of Antimicrobial Agents|August 2, 2019
Hot topics on procalcitonin use in clinical practice, can it help antibiotic stewardship?Kordo Saeed, Juan González Del Castillo, Craig Backous, et al.
Pageof 32

Showing results (181-190 of 319) with videos related to

Sort By:
Pageof 32
Frontiers in Immunology|June 18, 2021
Hemadsorption as a Treatment Option for Multisystem Inflammatory Syndrome in Children Associated With COVID-19. A Case ReportJuan Carlos Ruiz-Rodríguez, Luis Chiscano-Camón, Clara Palmada, et al.
Archivos De Bronconeumologia|September 27, 2022
Hyperglycemia in Acute Critically Ill COVID-19 PatientsCatia Cilloniz, Juan M Pericàs, Anna Motos, et al.
Frontiers in Immunology|December 6, 2021
JAK2-STAT Epigenetically Regulates Tolerized Genes in Monocytes in the First Encounter With Gram-Negative Bacterial Endotoxins in SepsisOctavio Morante-Palacios, Clara Lorente-Sorolla, Laura Ciudad, et al.
Intensive Care Medicine|January 2, 2023
How to use biomarkers of infection or sepsis at the bedside: guide to cliniciansPedro Póvoa, Luís Coelho, Felipe Dal-Pizzol, et al.
Critical Care Explorations|October 16, 2020
Extracorporeal Membrane Oxygenation Retrieval in Coronavirus Disease 2019: A Case-Series of 19 Patients Supported at a High-Volume Extracorporeal Membrane Oxygenation CenterJordi Riera, Eduard Argudo, María Martínez-Martínez, et al.
International Angiology : a Journal of the International Union of Angiology|November 9, 2021
Mortality and bleeding complications of COVID-19 critically ill patients with venous thromboembolismDaniel Gil-Sala, Claudia Riera, Marvin García-Reyes, et al.
Antibiotics (Basel, Switzerland)|January 25, 2025
Correction: Kirkegaard-Biosca et al. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. <i>Antibiotics</i> 2024, <i>13</i>, 874Cristina Kirkegaard-Biosca, Ester Del Barrio-Tofiño, Miguel Villamarín, et al.
Antibiotics (Basel, Switzerland)|September 28, 2024
Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative BacteriaCristina Kirkegaard-Biosca, Ester Del Barrio-Tofiño, Miguel Villamarín, et al.
The Lancet. Infectious Diseases|October 15, 2020
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trialMatteo Bassetti, Roger Echols, Yuko Matsunaga, et al.
International Journal of Antimicrobial Agents|August 2, 2019
Hot topics on procalcitonin use in clinical practice, can it help antibiotic stewardship?Kordo Saeed, Juan González Del Castillo, Craig Backous, et al.
Pageof 32